BriaCell Therapeutics Corp’s filing revealed that its Director Lustig Marc acquired Company’s shares for reported $2.0 million on May 14
BriaCell Therapeutics Corp’s recently made public that its Director Lustig Marc acquired Company’s shares for reported $2.0 million on May
BriaCell Therapeutics Corp’s recent filing unveils that its Director Lustig Marc acquired Company’s shares for reported $2.0 million on May
In a filing, BriaCell Therapeutics Corp revealed its Director Lustig Marc acquired Company’s shares for reported $2.0 million on May
In a filing, BriaCell Therapeutics Corp revealed its Director Lustig Marc acquired Company’s shares for reported $2.0 million on May
